WILD CARD: Will China be able to cure diabetes with all its money flowing into pharm or will we continue to use 1921 technology called Insulin shots?
Our BETA blog’s motto is “Say Provocative statements that intelligent people argue about fast without dotting your I’s and crossing your T’s. As life is all about fun and results!” – JD Morris
“When will we find solutions vs band-aids for many of our medical our medical problems. Band-aids can be very profitable, but NIH and others should have solved these problems with all their funding.” – JD Morris
IN PIPELINE – VENTURE CAPITAL – 09-05-2018
|• Jianke, a China-based online B2C pharmacy and healthcare services platform, raised $130 million in Series B funding. GTJA Investment Group led the round, and was joined by investors including HBM Healthcare Investments and Crescent Point.
• Auterion, a Switzerland-based open source drone software company, raised $10 million in seed funding. Investors include Lakestar, Mosaic Ventures, Costanoa Ventures, and Tectonic Ventures.
• Duffel, a London-based travel startup, raised $4.7 million in funding. Blossom Capital led the round, and was joined by investors including The Crankstart Foundation and Index Ventures.
• Phrasee, a London-based developer of marketing language generation software, raised $4 million in Series A funding. Albion Capital Group led the round, and was joined by investors including Next Fifteen andGalvanise Capital.
• Upfluence, a New York-based SaaS influencer marketing platform, raised $3.6 million in Series A funding. ISAI led the round, and was joined by investors including French Partners.